Sign in
CompletedNo phase

Study on the Construction and Application of Breastfeeding Behavior Intervention Program for Mothers of Infants With Congenital Heart Disease

Key facts

Who runs it
Children's Hospital of Fudan University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
68 people enrolled
Started
25 Apr 2023
Ended
30 May 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Conventional care
  • Breastfeeding behavioural intervention for mothers of infants with CHD
Record updated
17 July 2024

Who can take part

Age
1 day to 6 months
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • For infants; CHD was diagnosed within 14 days of birth; From birth to 14 days old; Exclusive breastfeeding or mixed feeding during enrollment
  • For mothers; The mother is the primary caretaker for the infant with CHD; The mother has a smartphone and has the skills to use it; She has good reading and communication skills and can work fully with others; In good physical health with no clear disability, such as severe cardiovascular disease, etc; In good mental health, without any clearly diagnosed anxiety disorders, depression, etc; Mothers must be at least 18 years old

Who cannot take part

  • For infants; Congenital anomalies such as gastrointestinal anomalies, facial anomalies, cleft lip and palate, and various syndromes due to chromosomal abnormalities are combined; Cardiac surgery was performed within 14 days of birth; The infant is not breastfed according to medical standards (for example, with galactosemia, phenylketonuria, or maple glycosuria)
  • For mothers; Mothers with mental illness, cognitive impairment, etc. who struggle to communicate effectively; Those who have contraindications to breastfeeding, such as long-term use of specific types of drugs such as chemotherapy drugs, opioids, anti-epileptic drugs, anti-depressants, psychotropic drugs, etc; Systemic infectious diseases during feeding include HIV positive, active or untreated tuberculosis, recent syphilis infection, etc

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is a randomized block trial designed to evaluate the effectiveness of a breastfeeding behavioural intervention program for mothers of infants with congenital heart disease (CHD). The purpose of this study is to compare exclusive breastfeeding rates, changes in weight-for-age z-scores (ΔWAZ) and height-for-age z-scores (ΔHAZ), and maternal breastfeeding behaviour between the intervention group and the control group at 1, 3, and 6 months of age.

The 2 groups in the trial

  • Conventional care groupOther group

    The management of infants with CHD and their mothers is based on the current breastfeeding process and care protocols at the Cardiovascular Centre of the Children's Hospital of Fudan University.

    Treatment: Conventional care

  • Breastfeeding intervention programTreatment being tested

    Implement intervention programs to improve breastfeeding behaviour among mothers of infants with CHD and observe ongoing changes.

    Treatment: Breastfeeding behavioural intervention for mothers of infants with CHD

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 July 2024